Molecular Partners Reports H1 2023 Corporate Highlights and Financials

The first clinical trial of a new type of T cell engager candidate has been announced at the Advertising and Clinical Advisory Council (asco), according to latest data released by the company's chief medical officer, Colin Powell.

Source: streetinsider.com
Published on 2023-08-24